Article
The role of HIV type 1 phenotype and genotype in long-term responders to zidovudine therapy.
AIDS research and human retroviruses - 20 Jul 1996
Angarano G, Monno L, Vivirito M C, Appice A, Romanelli C, Giannelli A, La Grasta L, Fracasso C, Fiore J R, Milazzo F
Abstract excerpt
We performed a cross-sectional and partly retrospective virological evaluation of 31 long-term responders (LTRs) to zidovudine (ZDV) (persistent increase in the CD4+ cell counts without progression of HIV infection throughout a period of ZDV therapy > 3 years) and 17 well-matched controls who developed a marked immunological deterioration over a 24-month period of ZDV therapy. The biological phenotype of HIV-1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.